Equine herpesvirus recombinant poxvirus vaccine
US5482713A · kind A · utility
Assignee
Inventor
Key dates
| Filing date | Sep 21, 1993 |
| Grant date | Jan 9, 1996 |
| Priority date | — |
| Expiry date | Sep 21, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/20022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
What is described is a recombinant poxvirus, such as vaccinia virus, fowlpox virus and canarypox virus, containing foreign DNA from herpesvirus. In one embodiment, the foreign DNA is expressed in a host by the production of a herpesvirus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two, particularly two or three, herpesvirus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, the barrier of maternal immunity in a newborn offspring can be overcome or avoided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.